Instituto COI de Pesquisa

Rio de Janeiro 22793-080

0 studies enrolling now · 2 studies all time

What they study most

Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Solid Cancer, Squamous Cell Carcinoma (SCC)

Studies at this site

• A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Recruiting now
• Study of Cemiplimab in Adults With Cervical Cancer — Completed